- Heart transplant recipients at increased risk for skin cancers
- No greater CV benefit with fenofibrate plus statin vs. statin alone in diabetes
- Lipid improvements attained up to two years with fenofibric acid plus rosuvastatin
- NAVIGATOR: Valsartan slowed progression to diabetes, no effect on CV events
- Insulin-sensitizing therapy increased LDL particle size, concentration after one year
